AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
In 2017, electronic cigarettes (e-cigarettes) were the most commonly used tobacco product among high and middle school students. Many...
The past month has seen the U.S. Food and Drug Administration (FDA) expand the use of four anticancer therapeutics,...
Today, the American Association for Cancer Research (AACR) released its eighth annual Cancer Progress Report. The report highlights how...
Building upon the success of the African Cancer Researchers Travel Awards, the American Association for Cancer Research is pleased...
As a predoctoral student in the Integrated Biomedical Sciences Graduate Program at The Ohio State University in 2005, Bethany...
Immuno-oncology has revolutionized treatment for certain types of cancers, but currently it is only effective for about 20 percent...
The American Association for Cancer Research (AACR) began publishing scientific articles in 1916, and now proudly publishes eight peer-reviewed...
AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently hit another milestone: the public release of a fourth dataset,...
Anthracyclines, a widely used class of chemotherapeutics, work in several ways to kill rapidly dividing cells, including those found...
This past April, the American Association for Cancer Research welcomed its 2018 class of African Cancer Researchers Travel Award...